Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry

Table 3 Results of the Six-minute walking test distance of the whole CHF population classified as Euglycemic, IR, and DM

Characteristics	Study cohort	Euglycemic	IR	T2D	ANOVA F-value	Kruskal–Wallis Chi-squared	p-value
Heart Rate (bpm) (T0)	68 [60–75]	65 [60–73, 5]	68 [62–77]*	72 [64–76]*	5.5		< 0.01
sPO₂ (%) (T0)	97 [96–98]	97 [95–98]	97 [96–98]	97 [96–98]	0.5		0.6
Fatigue Borg Scale (T0)	0 [0–1]	0 [0–0.6]	0 [0–1]	0 [0–1]	–	1.8	–
Distance (m)	380 ± 102	397 ± 101	386 ± 107	352 ± 93*^,§	3.6		< 0.01
sPO₂ MAX (%)	98 [97–99]	98 [97–99]	98 [97–98]	98 [97–98]	0.8		0.45
sPO₂MIN (%)	96 [94–97]	95 [94–97]	96 [94–97]	96]94–97]	0.3		0.8
HR MAX (bpm)	85 [75–97.2]	84 [73–98]	87 [76–97]	85 [77–94]	0.9		0.4
Heart Rate (end) (bpm)	80 [70–90]	76 [68–86.5]	80 [70–93]	81 [72–92]	2.3		0.1
sPO₂ (end) (%)	97 [95–98]	97 [95–98]	97 [96–98]	97 [95–98]	0.3		0.7
Fatigue Borg Scale (End)	2 [1–3]	1 [0.5–3]	2 [1–4]	2 [1–3]		3	0.2

ISSN: 1475-2840